4.7 Article

Connectivity from the ventral anterior cingulate to the amygdala is modulated by appetitive motivation in response to facial signals of aggression

期刊

NEUROIMAGE
卷 43, 期 3, 页码 562-570

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.neuroimage.2008.07.045

关键词

Aggression; Behavioural approach/behavioural; inhibition system; Individual differences; Effective connectivity; fMRI; Emotion regulation

资金

  1. Medical Research Council (MRC) [1055.02.001.00001.01]
  2. Wellcome Trust Development
  3. MRC [MC_U105579214] Funding Source: UKRI
  4. Medical Research Council [MC_U105579214] Funding Source: researchfish

向作者/读者索取更多资源

For some people facial expressions of aggression are intimidating, for others they are perceived as provocative, evoking an aggressive response. Identifying the key neurobiological factors that underlie this variation is fundamental to our understanding of aggressive behaviour. The amygdala and the ventral anterior cingulate cortex (ACC) have been implicated in aggression. Using functional magnetic resonance imaging (fMRI), we studied how the interaction between these regions is influenced by the drive to obtain reward (reward-drive or appetitive motivation), a personality trait consistently associated with aggression. Two distinct techniques showed that the connectivity between the ventral ACC and the amygdala was strongly correlated with personality, with high reward-drive participants displaying reduced negative connectivity. Furthermore, the direction of this effect was restricted from ventral ACC to the amygdala but not vice versa. The personality-mediated variation in the pathway from the ventral anterior cingulate cortex to the amygdala provides an account of why signals of aggression are interpreted as provocative by some individuals more than others. (C) 2008 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

A modified Camel and Cactus Test detects presymptomatic semantic impairment in genetic frontotemporal dementia within the GENFI cohort

Katrina Moore, Rhian Convery, Martina Bocchetta, Mollie Neason, David M. Cash, Caroline Greaves, Lucy L. Russell, Mica T. M. Clarke, Georgia Peakman, John van Swieten, Lize Jiskoot, Fermin Moreno, Myriam Barandiaran, Raquel Sanchez-Valle, Barbara Borroni, Robert Laforce, Marie-Claire Dore, Mario Masellis, Maria Carmela Tartaglia, Caroline Graff, Daniela Galimberti, James B. Rowe, Elizabeth Finger, Matthis Synofzik, Hans-Otto Karnath, Rik Vandenberghe, Alexandre de Mendonca, Carolina Maruta, Fabrizio Tagliavini, Isabel Santana, Simon Ducharme, Chris Butler, Alex Gerhard, Johannes Levin, Adrian Danek, Markus Otto, Jason D. Warren, Jonathan D. Rohrer, Martin N. Rossor, Nick C. Fox, Ione O. C. Woollacott, Rachelle Shafei, Carolin Heller, Rita Guerreiro, Jose Bras, David L. Thomas, Jennifer Nicholas, Simon Mead, Lieke Meeter, Jessica Panman, Janne Papma, Rick van Minkelen, Yolande Pijnenburg, Begona Indakoetxea, Alazne Gabilondo, Mikel Tainta, Maria de Arriba, Ana Gorostidi, Miren Zulaica, Jorge Villanua, Zigor Diaz, Sergi Borrego-Ecija, Jaume Olives, Albert Llado, Mircea Balasa, Anna Antonell, Nuria Bargallo, Enrico Premi, Maura Cosseddu, Stefano Gazzina, Alessandro Padovani, Roberto Gasparotti, Silvana Archetti, Sandra Black, Sara Mitchell, Ekaterina Rogaeva, Morris Freedman, Ron Keren, David Tang-Wa, Linn Oijerstedt, Christin Andersson, Vesna Jelic, Hakan Thonberg, Andrea Arighi, Chiara Fenoglio, Elio Scarpini, Giorgio Fumagalli, Thomas Cope, Carolyn Timberlake, Timothy Rittman, Christen Shoesmith, Robart Bartha, Rosa Rademakers, Carlo Wilke, Benjamin Bender, Rose Bruffaerts, Philip Van Damme, Mathieu Vandenbulcke, Catarina B. Ferreira, Gabriel Miltenberger, Ana Verdelho, Sonia Afonso, Ricardo Taipa, Paola Caroppo, Giuseppe Di Fede, Giorgio Giaccone, Sara Prioni, Veronica Redaelli, Giacomina Rossi, Pietro Tiraboschi, Diana Duro, Maria Rosario Almeida, Miguel Castelo-Branco, Maria Joao Leitao, Miguel Tabuas-Pereira, Beatriz Santiago, Serge Gauthier, Pedro Rosa-Neto, Michele Veldsman, Toby Flanagan, Catharina Prix, Tobias Hoegen, Elisabeth Wlasich, Sandra Loosli, Sonja Schonecker, Elisa Semler, Sarah Anderl-Straub

Summary: This study investigates semantic cognition in patients with genetic frontotemporal dementia (FTD). The study finds that symptomatic patients scored lower than controls on semantic knowledge, while only late-stage MAPT and C9orf72 mutation carriers scored lower than controls in the presymptomatic groups. Furthermore, the study shows a correlation between mCCT score and brain volume in different regions in different mutation groups.

APPLIED NEUROPSYCHOLOGY-ADULT (2022)

Article Psychology, Clinical

Refining our understanding of depressive states and state transitions in response to cognitive behavioural therapy using latent Markov modelling

Ana Catarino, Jonathan M. Fawcett, Michael P. Ewbank, Sarah Bateup, Ronan Cummins, Valentin Tablan, Andrew D. Blackwell

Summary: This study used a data-driven approach to define depressive states and explore transitions between states in response to cognitive behavioural therapy (CBT). The results identified seven depressive states and showed that patients with cognitive/affective symptoms do not typically transition towards somatic states and vice-versa. Additionally, patients starting in a somatic depressive state are less likely to engage with or improve with therapy.

PSYCHOLOGICAL MEDICINE (2022)

Letter Clinical Neurology

Practice effects in genetic frontotemporal dementia and at-risk individuals: a GENFI study

Linn Oijerstedt, Christin Andersson, Vesna Jelic, John Cornelis van Swieten, Lize C. Jiskoot, Harro Seelaar, Barbara Borroni, Raquel Sanchez-Valle, Fermin Moreno, Robert Laforce, Matthis Synofzik, Daniela Galimberti, James Benedict Rowe, Mario Masellis, Maria Carmela Tartaglia, Elizabeth Finger, Rik Vandenberghe, Alexandre de Mendonca, Fabrizio Tagliavini, Isabel Santana, Simon Ducharme, Christopher R. Butler, Alexander Gerhard, Johannes Levin, Adrian Danek, Markus Otto, Giovanni Frisoni, Roberta Ghidoni, Sandro Sorbi, Jonathan Daniel Rohrer, Caroline Graff

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2022)

Article Clinical Neurology

Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study

Carlo Wilke, Selina Reich, John C. van Swieten, Barbara Borroni, Raquel Sanchez-Valle, Fermin Moreno, Robert Laforce, Caroline Graff, Daniela Galimberti, James B. Rowe, Mario Masellis, Maria C. Tartaglia, Elizabeth Finger, Rik Vandenberghe, Alexandre de Mendonca, Fabrizio Tagliavini, Isabel Santana, Simon Ducharme, Chris R. Butler, Alexander Gerhard, Johannes Levin, Adrian Danek, Markus Otto, Giovanni Frisoni, Roberta Ghidoni, Sandro Sorbi, Martina Bocchetta, Emily Todd, Jens Kuhle, Christian Barro, Jonathan D. Rohrer, Matthis Synofzik

Summary: This study provides a biomarker cascade for the conversion stage in presymptomatic frontotemporal dementia, using serum neurofilament levels to stratify individuals in different stages and potentially identify those converting to symptomatic disease. The biomarker cascade may pave the way towards a biomarker-based precision medicine approach to genetic FTD.

ANNALS OF NEUROLOGY (2022)

Article Clinical Neurology

A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia

Emma L. van der Ende, Esther E. Bron, Jackie M. Poos, Lize C. Jiskoot, Jessica L. Panman, Janne M. Papma, Lieke H. Meeter, Elise G. P. Dopper, Carlo Wilke, Matthis Synofzik, Carolin Heller, Imogen J. Swift, Aitana Sogorb-Esteve, Arabella Bouzigues, Barbara Borroni, Raquel Sanchez-Valle, Fermin Moreno, Caroline Graff, Robert Laforce, Daniela Galimberti, Mario Masellis, Maria Carmela Tartaglia, Elizabeth Finger, Rik Vandenberghe, James B. Rowe, Alexandre de Mendonca, Fabrizio Tagliavini, Isabel Santana, Simon Ducharme, Christopher R. Butler, Alexander Gerhard, Johannes Levin, Adrian Danek, Markus Otto, Yolande A. L. Pijnenburg, Sandro Sorbi, Henrik Zetterberg, Wiro J. Niessen, Jonathan D. Rohrer, Stefan Klein, John C. van Swieten, Vikram Venkatraghavan, Harro Seelaar

Summary: This study aimed to model the sequence of biomarker abnormalities in genetic frontotemporal dementia and determine the disease stages of patients. The results showed that NPTX2 and neurofilament light chain were the earliest biomarkers to change. This model could help select suitable patients for pharmaceutical trials and improve patient stratification and tracking of therapeutic interventions.
Letter Clinical Neurology

Are the UK genetic testing criteria for dementia too exclusive?

Annita Christodoulidou, Georgina E. McKenna, Simon T. Holden, James B. Rowe, Thomas E. Cope

JOURNAL OF NEUROLOGY (2022)

Article Neurosciences

Neurophysiological and Brain Structural Markers of Cognitive Frailty Differ from Alzheimer's Disease

Ece Kocagoncu, David Nesbitt, Tina Emery, Laura E. Hughes, Richard N. Henson, James B. Rowe

Summary: The study focuses on cognitive frailty and compared the structural and neurophysiological properties of cognitively frail adults with Alzheimer’s disease and mild cognitive impairment. The results suggest that cognitive frailty may represent a spectrum of normal aging rather than the onset of Alzheimer’s disease.

JOURNAL OF NEUROSCIENCE (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

In Vivo 18F-Flortaucipir PET Does Not Accurately Support the Staging of Progressive Supranuclear Palsy

Maura Malpetti, Sanne S. Kaalund, Kamen A. Tsvetanov, Timothy Rittman, Mayen Briggs, Kieren S. J. Allinson, Luca Passamonti, Negin Holland, P. Simon Jones, Tim D. Fryer, Young T. Hong, Antonina Kouli, W. Richard Bevan-Jones, Elijah Mak, George Savulich, Maria Grazia Spillantini, Franklin Aigbirhio, Caroline H. Williams-Gray, John T. O'Brien, James B. Rowe

Summary: The study found that F-18-flortaucipir PET does not correspond to neuropathologic staging in PSP. The analytic approach seeking to mirror in vivo neuropathology staging with PET-to-autopsy correlational analyses might enable in vivo staging with next-generation tau PET tracers; however, further evidence and comparisons with postmortem data are needed.

JOURNAL OF NUCLEAR MEDICINE (2022)

Article Multidisciplinary Sciences

Dynamic targeting enables domain-general inhibitory control over action and thought by the prefrontal cortex

Dace Apsvalka, Catarina S. Ferreira, Taylor W. Schmitz, James B. Rowe, Michael C. Anderson

Summary: This study demonstrates that inhibitory control activates the right dorsolateral and ventrolateral prefrontal cortex to suppress diverse content, and these regions play a crucial role in action and thought stopping.

NATURE COMMUNICATIONS (2022)

Article Clinical Neurology

Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations

Arabella Bouzigues, Lucy L. Russell, Georgia Peakman, Martina Bocchetta, Caroline Greaves, Rhian S. Convery, Emily Todd, James B. Rowe, Barbara Borroni, Daniela Galimberti, Pietro Tiraboschi, Mario Masellis, Maria Carmela Tartaglia, Elizabeth Finger, John C. van Swieten, Harro Seelaar, Lize Jiskoot, Sandro Sorbi, Chris R. Butler, Caroline Graff, Alexander Gerhard, Tobias Langheinrich, Robert Laforce, Raquel Sanchez-Valle, Alexandre de Mendonca, Fermin Moreno, Matthis Synofzik, Rik Vandenberghe, Simon Ducharme, Isabelle Le Ber, Johannes Levin, Adrian Danek, Markus Otto, Florence Pasquier, Isabel Santana, Jonathan D. Rohrer

Summary: This study finds that MAPT mutation carriers develop early naming impairments likely associated with semantic knowledge deficits, while C9orf72 and GRN mutation carriers can have more widespread brain atrophy.

JOURNAL OF NEUROLOGY (2022)

Article Neurosciences

Causal Evidence for the Multiple Demand Network in Change Detection: Auditory Mismatch Magnetoencephalography across Focal Neurodegenerative Diseases

Thomas E. Cope, Laura E. Hughes, Holly N. Phillips, Natalie E. Adams, Amirhossein Jafarian, David Nesbitt, Moataz Assem, Alexandra Woolgar, John Duncan, James B. Rowe

Summary: The study demonstrates the causal role of the multiple demand (MD) network in automatic auditory change detection, showing that atrophy of any MD node impairs auditory neurophysiological response. Different neurodegenerative syndromes display altered connectivity within the MD network, with evidence of partially effective compensation mechanisms. Damage to any node of the MD network is found to impair top-down control of sensation, providing a common mechanism for impaired change detection across dementia syndromes.

JOURNAL OF NEUROSCIENCE (2022)

Article Neurosciences

Prefrontal Cortical Connectivity Mediates Locus Coeruleus Noradrenergic Regulation of Inhibitory Control in Older Adults

Alessandro Tomassini, Frank H. Hezemans, Rong Ye, Kamen A. Tsvetanov, Noham Wolpe, James B. Rowe

Summary: This study confirms the association between locus coeruleus integrity and response inhibition ability using MRI imaging. It also demonstrates that the connectivity between presupplementary motor area (preSMA) and right inferior frontal gyrus (rIFG) plays a mediating role in this association. These findings suggest that the locus coeruleus noradrenergic system regulates inhibitory control in healthy individuals.

JOURNAL OF NEUROSCIENCE (2022)

Article Neurosciences

A synergistic core for human brain evolution and cognition

Andrea Luppi, Pedro A. M. Mediano, Fernando E. Rosas, Negin Holland, Tim D. Fryer, John T. O'Brien, James B. Rowe, David K. Menon, Daniel Bor, Emmanuel A. Stamatakis

Summary: This study decomposes neural information into synergistic and redundant components, showing the role of core brain regions in supporting higher cognition and demonstrating that humans leverage synergistic information more than macaques. The study also reveals the distinct roles of redundant and synergistic interactions in neural information processing.

NATURE NEUROSCIENCE (2022)

Review Clinical Neurology

Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer's disease: systematic review and meta-analysis

Michael C. B. David, Martina Del Giovane, Kathy Y. Liu, Benjamin Gostick, James Benedict Rowe, Imafidon Oboh, Robert Howard, Paresh A. Malhotra

Summary: This study assessed the efficacy of drugs with noradrenergic action in improving cognitive and neuropsychiatric symptoms in Alzheimer's disease. The findings showed a small positive effect on global cognition and a large positive effect on apathy. This suggests that repurposing established noradrenergic drugs may offer effective treatment for certain symptoms in Alzheimer's disease.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2022)

Article Clinical Neurology

A robust harmonization approach for cognitive data from multiple aging and dementia cohorts

Joseph Giorgio, Ankeet Tanna, Maura Malpetti, Simon R. White, Jingshen Wang, Suzanne Baker, Susan Landau, Tomotaka Tanaka, Christopher Chen, James B. Rowe, John O'Brien, Jurgen Fripp, Michael Breakspear, William Jagust, Zoe Kourtzi

Summary: This study used a two-stage approach to harmonize cognitive data from different cohorts and derive a cross-cohort score for cognitive impairment due to AD. The results showed that the cognitive composites were robust across cohorts and achieved comparable sensitivity to AD-related cognitive decline. This approach offers a simple and effective way for researchers to harmonize and pool cognitive data for the study of cognitive decline in AD.

ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2023)

Article Neurosciences

Solving large-scale MEG/EEG source localisation and functional connectivity problems simultaneously using state-space models

Jose Sanchez-Bornot, Roberto C. Sotero, J. A. Scott Kelso, Ozguer Simsek, Damien Coyle

Summary: This study proposes a multi-penalized state-space model for analyzing unobserved dynamics, using a data-driven regularization method. Novel algorithms are developed to solve the model, and a cross-validation method is introduced to evaluate regularization parameters. The effectiveness of this method is validated through simulations and real data analysis, enabling a more accurate exploration of cognitive brain functions.

NEUROIMAGE (2024)